导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.73% | 327/1050 |
| 近一周 | -2.61% | 850/1104 |
| 近一月 | -0.91% | 219/1103 |
| 近一季 | -9.36% | 671/1092 |
| 近半年 | 7.83% | 292/1070 |
| 近一年 | 6.26% | 449/1018 |
| 近两年 | 57.59% | 462/926 |
| 近三年 | 21.90% | 483/834 |
| 成立以来 | 20.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.36% 773/1070 |
31.14% 308/1101 |
- - |
- - |
| 2025 | 28.45% 499/1065 |
14.12% 62/1014 |
-0.28% 714/1038 |
20.36% 599/1050 |
-6.22% 753/1065 |
| 2024 | -0.85% 605/1011 |
-6.73% 650/960 |
2.52% 171/983 |
9.39% 672/991 |
-5.21% 684/1011 |
| 2023 | -21.80% 716/952 |
-3.76% 766/880 |
-6.68% 624/895 |
-4.65% 282/915 |
-8.68% 797/952 |
| 2022 | -20.09% 324/867 |
-17.02% 360/773 |
3.70% 596/806 |
-15.36% 586/845 |
9.72% 84/867 |
| 2021 | -5.73% 426/740 |
-2.71% 252/580 |
20.18% 161/659 |
-9.26% 489/704 |
-11.15% 668/740 |
| 2020 | 44.32% 271/554 |
-5.09% 291/419 |
24.78% 196/466 |
7.29% 316/517 |
13.58% 237/554 |
| 2019 | 15.29% 338/410 |
13.30% 1026/1146 |
0.37% 292/1228 |
-4.97% 372/390 |
6.69% 286/410 |
| 2018 | -27.32% 182/349 |
- - |
1.21% 56/990 |
-11.27% 827/1000 |
-13.96% 824/1080 |
| 2017 | 29.20% 45/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 汇添富沪港深新价值股票 VS. 东吴新产业精选股票A(580008) |